Article Details

Piper Sandler Analysts Decrease Earnings Estimates for bluebird bio, Inc. (NASDAQ:BLUE)

Retrieved on: 2021-03-15 06:45:00

Tags for this article:

Click the tags to see associated articles and topics

Piper Sandler Analysts Decrease Earnings Estimates for bluebird bio, Inc. (NASDAQ:BLUE). View article details on hiswai:

Excerpt

The biotechnology company reported ($3.01) EPS for the quarter, missing analysts' consensus estimates of ($2.96) by ($0.05). bluebird bio had a ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up